Barry Labinger Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Barry Labinger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barry Labinger. Barry Labinger is a Exec VP & CCO in HUMAN GENOME SCIENCES INC ($HGSI) and a Exec VP, CCO & CFO in HUMAN GENOME SCIENCES INC ($HGSI) and a EVP, Biosciences Div. in Emergent BioSolutions Inc. ($EBS) and a President and CEO in Checkmate Pharmaceuticals, Inc. ($CMPI).
Address: 14200 SHADY GROVE ROAD ROCKVILLE 20850 MD
Companies in which Barry Labinger is an Insider
Checkmate Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Barry Labinger: President and CEO
Holdings: 0 shares
Latest Transaction: Aug 10 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Emergent BioSolutions Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Barry Labinger: EVP, Biosciences Div.
Holdings: 25,182 shares
Current Value: $739,092
Latest Transaction: Nov 17 2015
$EBS Market Capitalization: $1.21B
$EBS Previous Close: $29.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HUMAN GENOME SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Barry Labinger: Exec VP & CCO, Exec VP, CCO & CFO
Holdings: 0 shares
Latest Transaction: Aug 01 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Barry Labinger
Sentiment: All, CMPI, EBS, HGSI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2020 | CMPI | Checkmate Pharmace ... | Labinger Barry | President and CEO | Option Exercise | A | 15.00 | 445,819 | 6,687,285 | 445,819 | |
| Nov 17 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.50 | 3,376 | 123,224 | 25,182 | 28.6 K to 25.2 K (-11.82 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,094 | 211,368 | 0 | |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 20.94 | 10,095 | 211,389 | 0 | |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Option Exercise | M | 28.09 | 9,373 | 263,288 | 0 | |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Payment of Exercise | F | 35.88 | 1,671 | 59,955 | 28,558 | 30.2 K to 28.6 K (-5.53 %) |
| Nov 13 2015 | EBS | Emergent BioSoluti ... | Labinger Barry | EVP, Biosciences Di ... | Sell | S | 36.00 | 10,094 | 363,384 | 30,229 | 40.3 K to 30.2 K (-25.03 %) |